RATIONALE: Polymorphisms affecting Toll-like receptor (TLR)-mediated responses could predispose to excessive inflammation during an infection and contribute to an increased risk for poor outcomes in patients with sepsis. OBJECTIVES: To identify hypermorphic polymorphisms causing elevated TLR-mediated innate immune cytokine and chemokine responses and to test whether these polymorphisms are associated with increased susceptibility to death, organ dysfunction, and infections in patients with sepsis. METHODS: We screened single-nucleotide polymorphisms (SNPs) in 43 TLR-related genes to identify variants affecting TLR-mediated inflammatory responses in blood from healthy volunteers ex vivo. The SNP associated most strongly with hypermorphic responses was tested for associations with death, organ dysfunction, and type of infection in two studies: a nested case-control study in a cohort of intensive care unit patients with sepsis, and a case-control study using patients with sepsis, patients with sepsis-related acute lung injury, and healthy control subjects. MEASUREMENTS AND MAIN RESULTS: The SNP demonstrating the most hypermorphic effect was the G allele of TLR1(-7202A/G) (rs5743551), which associated with elevated TLR1-mediated cytokine production (P < 2 x 10(-20)). TLR1(-7202G) marked a coding SNP that causes higher TLR1-induced NF-kappaB activation and higher cell surface TLR1 expression. In the cohort of patients with sepsis TLR1(-7202G) predicted worse organ dysfunction and death (odds ratio, 1.82; 95% confidence interval, 1.07-3.09). In the case-control study TLR1(-7202G) was associated with sepsis-related acute lung injury (odds ratio, 3.40; 95% confidence interval, 1.59-7.27). TLR1(-7202G) also associated with a higher prevalence of gram-positive cultures in both clinical studies. CONCLUSIONS: Hypermorphic genetic variation in TLR1 is associated with increased susceptibility to organ dysfunction, death, and gram-positive infection in sepsis.
RATIONALE: Polymorphisms affecting Toll-like receptor (TLR)-mediated responses could predispose to excessive inflammation during an infection and contribute to an increased risk for poor outcomes in patients with sepsis. OBJECTIVES: To identify hypermorphic polymorphisms causing elevated TLR-mediated innate immune cytokine and chemokine responses and to test whether these polymorphisms are associated with increased susceptibility to death, organ dysfunction, and infections in patients with sepsis. METHODS: We screened single-nucleotide polymorphisms (SNPs) in 43 TLR-related genes to identify variants affecting TLR-mediated inflammatory responses in blood from healthy volunteers ex vivo. The SNP associated most strongly with hypermorphic responses was tested for associations with death, organ dysfunction, and type of infection in two studies: a nested case-control study in a cohort of intensive care unit patients with sepsis, and a case-control study using patients with sepsis, patients with sepsis-related acute lung injury, and healthy control subjects. MEASUREMENTS AND MAIN RESULTS: The SNP demonstrating the most hypermorphic effect was the G allele of TLR1(-7202A/G) (rs5743551), which associated with elevated TLR1-mediated cytokine production (P < 2 x 10(-20)). TLR1(-7202G) marked a coding SNP that causes higher TLR1-induced NF-kappaB activation and higher cell surface TLR1 expression. In the cohort of patients with sepsis TLR1(-7202G) predicted worse organ dysfunction and death (odds ratio, 1.82; 95% confidence interval, 1.07-3.09). In the case-control study TLR1(-7202G) was associated with sepsis-related acute lung injury (odds ratio, 3.40; 95% confidence interval, 1.59-7.27). TLR1(-7202G) also associated with a higher prevalence of gram-positive cultures in both clinical studies. CONCLUSIONS: Hypermorphic genetic variation in TLR1 is associated with increased susceptibility to organ dysfunction, death, and gram-positive infection in sepsis.
Authors: Sameena S Khan; Meghan S Smith; Debra Reda; Anthony F Suffredini; J Philip McCoy Journal: Cytometry B Clin Cytom Date: 2004-09 Impact factor: 3.058
Authors: Kevin L Gunderson; Semyon Kruglyak; Michael S Graige; Francisco Garcia; Bahram G Kermani; Chanfeng Zhao; Diping Che; Todd Dickinson; Eliza Wickham; Jim Bierle; Dennis Doucet; Monika Milewski; Robert Yang; Chris Siegmund; Juergen Haas; Lixin Zhou; Arnold Oliphant; Jian-Bing Fan; Steven Barnard; Mark S Chee Journal: Genome Res Date: 2004-04-12 Impact factor: 9.043
Authors: G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg Journal: Am J Respir Crit Care Med Date: 1994-03 Impact factor: 21.405
Authors: A M Taveira da Silva; H C Kaulbach; F S Chuidian; D R Lambert; A F Suffredini; R L Danner Journal: N Engl J Med Date: 1993-05-20 Impact factor: 91.245
Authors: Richard P Darveau; Thu-Thao T Pham; Kayde Lemley; Robert A Reife; Brian W Bainbridge; Stephen R Coats; William N Howald; Sing Sing Way; Adeline M Hajjar Journal: Infect Immun Date: 2004-09 Impact factor: 3.441
Authors: Thomas R Hawn; Annelies Verbon; Kamilla D Lettinga; Lue Ping Zhao; Shuying Sue Li; Richard J Laws; Shawn J Skerrett; Bruce Beutler; Lea Schroeder; Alex Nachman; Adrian Ozinsky; Kelly D Smith; Alan Aderem Journal: J Exp Med Date: 2003-11-17 Impact factor: 14.307
Authors: Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze Journal: Microbiol Mol Biol Rev Date: 2012-03 Impact factor: 11.056
Authors: Theo S Plantinga; Melissa D Johnson; William K Scott; Esther van de Vosse; Digna R Velez Edwards; P Brian Smith; Barbara D Alexander; John C Yang; Dennis Kremer; Gregory M Laird; Marije Oosting; Leo A B Joosten; Jos W M van der Meer; Jaap T van Dissel; Thomas J Walsh; John R Perfect; Bart Jan Kullberg; Mihai G Netea Journal: J Infect Dis Date: 2012-02-01 Impact factor: 5.226
Authors: Laura C Whitmore; Jessica S Hook; Amanda R Philiph; Brieanna M Hilkin; Xinyu Bing; Chul Ahn; Hector R Wong; Polly J Ferguson; Jessica G Moreland Journal: J Immunol Date: 2016-01-04 Impact factor: 5.422
Authors: Olga Barca-Mayo; Xiao-Hui Liao; Caterina DiCosmo; Alexandra Dumitrescu; Liliana Moreno-Vinasco; Michael S Wade; Saad Sammani; Tamara Mirzapoiazova; Joe G N Garcia; Samuel Refetoff; Roy E Weiss Journal: Proc Natl Acad Sci U S A Date: 2011-11-07 Impact factor: 11.205
Authors: Stephen C Gale; Li Gao; Carmen Mikacenic; Susette M Coyle; Nicholas Rafaels; Tanda Murray Dudenkov; Jennifer H Madenspacher; David W Draper; William Ge; Jim J Aloor; Kathleen M Azzam; Lihua Lai; Perry J Blackshear; Steven E Calvano; Kathleen C Barnes; Stephen F Lowry; Siobhan Corbett; Mark M Wurfel; Michael B Fessler Journal: J Allergy Clin Immunol Date: 2014-03-18 Impact factor: 10.793
Authors: Koustav Ganguly; Timothy M Martin; Vincent J Concel; Swapna Upadhyay; Kiflai Bein; Kelly A Brant; Leema George; Ankita Mitra; Tania A Thimraj; James P Fabisiak; Louis J Vuga; Cheryl Fattman; Naftali Kaminski; Holger Schulz; George D Leikauf Journal: Am J Respir Cell Mol Biol Date: 2014-11 Impact factor: 6.914